Efficacy and safety of supramaximal titrated inhibition of renin‐angiotensin‐aldosterone system in idiopathic dilated cardiomyopathy

Publisher： John Wiley & Sons Inc

E-ISSN： 2055-5822|2|4|129-138

ISSN： 2055-5822

Source： ESC HEART FAILURE, Vol.2, Iss.4, 2015-12, pp. : 129-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The renin-angiotensin-aldosterone system: into the new millennium

By Ibrahim J.

Trends in Endocrinology and Metabolism, Vol. 12, Iss. 9, 2001-11 ,pp. : 421-423

Elsevier

Access to resources Recommend Favorite

Therapeutic Interventions to Renin-Angiotensin-Aldosterone System, and Vascular Redox State

Recent Patents on Cardiovascular Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 115-122

Bentham Science Publishers

Access to resources Recommend Favorite

Blockade of the Renin-Angiotensin-Aldosterone System: Effects on Hypertensive Target Organ Damage

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 4, Iss. 3, 2006-01 ,pp. : 219-228

Bentham Science Publishers

Access to resources Recommend Favorite

Renin–angiotensin–aldosterone system blockade in hypertensive patients with chronic kidney disease

Blood Pressure, Vol. 22, Iss. 6, 2013-12 ,pp. : 397-398

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil in Hypertension: Effects of Six Weeks' Treatment on Haemodynamics, Baroreceptor Sensitivity and the Renin-angiotensin-aldosterone System

By FRIDMAN KATARINA U. B. WYSOCKI MARIAN FRIBERG PETER R. ANDERSSON OVE K.

Blood Pressure, Vol. 8, Iss. 4, 1999-12 ,pp. : 242-247

Informa Healthcare

Access to resources Recommend Favorite